A diagnostic test kit for detecting multiple gene methylation markers in blood samples for intestinal cancer screening and diagnosis. The product is marketed under the brand name Chang Ai Ke® and represents an in vitro diagnostic solution for cancer detection.
Manufactured by
Singlera GENOMICS (SHANGHAI) Ltd.
China
Singlera Genomics is a China-based manufacturer of in vitro diagnostic (IVD) reagents and instruments specializing in DNA methylation-based cancer early detection and liquid biopsy testing. The company produces diagnostic products for multiple cancer types including colorectal, liver, gastric, esophageal, and pancreatic cancers, with manufacturing facilities in Yangzhou and Wuxi. Singlera holds ISO 13485 certification, CAP accreditation, US CLIA laboratory certification, and is designated as a National High-tech Enterprise in China.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Clinomics Europe Kft.
Hungary · 1 relevant product
BioChain (Beijing) Science & Technology. Inc.
China · 9 relevant products
Suzhou Linaxin Biotechnology Co., Ltd.
China · 6 relevant products
49 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →8 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 26 relevant matches
Clinomics Europe Kft. · Hungary
Multi-gene methylation detection test for colorectal cancer screening and risk assessment. Uses advanced liquid biopsy technology to identify epigenetic biomarkers associated with colorectal malignancy. Enables non-invasive early detection and personalized patient stratification for clinical decision-making.
BioChain (Beijing) Science & Technology. Inc. · China
A blood-based gene methylation detection kit for hepatocellular carcinoma with industry-leading performance metrics. This approved product is part of BioChain's comprehensive coverage of major digestive system cancers.
BioChain (Beijing) Science & Technology. Inc. · China
The world's first approved gene methylation early detection product for esophageal cancer, representing a breakthrough in early cancer diagnosis. This product has received NMPA certification and is part of BioChain's comprehensive digestive system cancer screening portfolio.
23 more relevant matches available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products